← Open Payments lookup

DIANE HANKS: Open Payments

NPI 1699747717 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,173 in 51 payments from 14 companies in 2025. Trend: 2023 $1,051 · 2024 $749 · 2025 $1,173

Food & beverage: $1,061Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.5$186
ABBVIE INC.6$156
Axsome Therapeutics, Inc.4$104
Takeda Pharmaceuticals U.S.A., Inc.5$102
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$99
Janssen Pharmaceuticals, Inc4$95
Alkermes, Inc.4$88
Neurocrine BioSciences, Inc.4$82
Supernus Pharmaceuticals, Inc.4$79
E.R. Squibb & Sons, L.L.C.2$52

Products named: VRAYLAR, Auvelity, TRINTELLIX, CAPLYTA, INVEGA SUSTENNA, INGREZZA, Qelbree, ARISTADA.

Industry payments across WA — which companies pay providers there.